Chitosan Chewing Gum Study in Dialysis Patients
Completed
Conditions studied: End Stage Renal Disease
In brief
The purpose of the pilot study is to determine the impact of short-term administration of chitosan-containing chewing gum on phosphate levels in patients with elevated serum phosphate levels.
Key facts
- Study ID
- NCT01770470
- Run by
- University of Maryland, Baltimore
- People needed
- 15
- Starts
- 2010-04-01
- Expected to finish
- 2011-01-01
- Last updated by the study team
- 2021-06-23
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18-64 years old
- ESRD receiving hemodialysis
- serum phosphate > 6.0 mg/dL
You may not qualify if…
- Unable to sign consent
Where it is running
- University of Maryland — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.